Segment Information and Concentrations

6 Months Ended

Dec. 31, 2011

Notes to Financial Statements

Segment Information and Concentrations

 The Company views its operations as three segments: the manufacture and marketing of standard benchtop laboratory equipment for research in university, hospital and industrial laboratories sold primarily through laboratory equipment distributors (ABenchtop Laboratory Equipment@), the manufacture and marketing of custom-made catalyst research instruments for universities, government laboratories, and chemical and petrochemical companies sold on a direct basis (ACatalyst Research Instruments@) and the marketing and production of bioprocessing systems for laboratory research in the biotechnology industry sold directly to customers and through distributors (“Bioprocessing Systems”).

Segment information is reported as follows:

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Three months ended December 31, 2011
Net Sales	$	1,108,500	$	89,100		$	—		$	—		$	1,197,600
Foreign Sales		755,100		112,000			—			—			867,100
Profit (Loss)		105,200		(117,800	)		(32,300	)		(33,600	)		(78,500	)
Assets		2,467,600		1,375,700			866,600			1,481,800			6,191,700
Long-Lived Asset Expenditures		4,500		2,800			876,000			—			883,300
Depreciation and Amortization		12,300		27,800			12,000			—			52,100

	Benchtop Laboratory Equipment		Catalyst Research Instruments		Bioprocessing Systems		Corporate and Other			Consolidated
Three months ended December 31, 2010
Net Sales	$	1,244,900	$	786,600	$	—	$	—		$	2,031,500
Foreign Sales		705,600		518,600		—		—			1,224,200
Profit (Loss)		247,400		43,300		—		(18,100	)		272,600
Assets		2,305,400		1,611,700		—		1,306,800			5,223,900
Long-Lived Asset Expenditures		34,300		20,700		—		—			55,000
Depreciation and Amortization		14,800		33,500		—		—			48,300

Approximately 63% and 70% of net sales of benchtop laboratory equipment (59% and 61% of total net sales) for the three month periods ended December 31, 2011 and 2010, respectively, were derived from that segment’s main product, the Vortex-Genie 2® mixer, excluding accessories.

Two benchtop laboratory equipment customers, accounted in the aggregate for approximately 26% and 36% of the segment's net sales (24% and 22% of total net sales) for the three month periods ended December 31, 2011 and 2010, respectively.

Sales of catalyst research instruments are generally pursuant to large orders averaging more than $100,000 per order to a limited numbers of customers. Sales to one customer during the three month period ended December 31, 2011 and to four other customers during the three month period ended December 31, 2010 accounted respectively for 73% and 67% of the segments net sales (25% and 26% of total net sales).

Six months ended December 31, 2011
		Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Net Sales	$	2,183,600	$	554,900		$	—		$	—		$	2,738,500
Foreign Sales		1,363,700		121,100			—			—			1,484,800
Profit (Loss)		272,400		(176,400	)		(32,300	)		(58,200	)		5,500
Assets		2,467,600		1,375,700			866,600			1,481,800			6,191,700
Long-Lived Asset Expenditures		14,000		49,500			876,000			—			939,500
Depreciation and Amortization		24,300		63,000			12,000			—			99,300
		Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Six months ended December 31, 2010
Net Sales	$	2,267,000	$	1,019,900		$	—		$	—		$	3,286,900
Foreign Sales		1,226,100		544,600			—			—			1,770,700
Profit (Loss)		379,600		(87,700	)		—			(16,100	)		275,800
Assets		2,305,400		1,611,700			—			1,306,800			5,223,900
Long-Lived Asset Expenditures		41,000		22,500			—			—			63,500
Depreciation and Amortization		28,600		67,000			—			—			95,600

Approximately 63% and 68% of net sales of benchtop laboratory equipment (50% and 47% of total net sales) for the six month periods ended December 31, 2011 and 2010, respectively, were derived from that segment’s main product, the Vortex-Genie 2® mixer, excluding accessories.

Two benchtop laboratory equipment customers, accounted in the aggregate for approximately 23% and 32% of the segment=s net sales respectively, and 19% and 22% of total net sales for the six month periods ended December 31, 2011 and 2010, respectively.

Sales of catalyst research instruments to four different customers, accounted respectively for approximately 88% and 43% of that segment’s net sales (18% and 13% of total net sales) for the six month period ended December 31, 2011 and 2010, respectively.

The Company’s foreign sales are principally made to customers in Europe and Asia.